Company Financials

Alnylam Pharmaceuticals, Inc. Financials

United States dollar

business Alnylam Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: ALNY

Market Capitalization $52.87 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 1242.66
Forward PE 35.56
Price to Sales TTM $16.37
Price to Book MRQ $224.03
Enterprise to Revenue 16.38
Enterprise to EBITDA 163.80

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 1.36%
Operating Margin 29.46%
Return on Assets TTM 3.65%
Return on Equity TTM 32.72%

Income Statement

Revenue TTM $3,210,070,016
Revenue per Share TTM $24.65
Quarterly Revenue Growth 149.30%
Gross Profit TTM $2,693,104,896
EBITDA $321,020,992
Net Income to Common TTM $43,565,000
Diluted EPS TTM $0.32
Quarterly Earnings Growth YoY 149.35%

Balance Sheet

Total Cash MRQ $2,724,623,872
Total Cash per Share MRQ $20.62
Total Debt MRQ $
Total Debt to Equity MRQ 1185.71
Current Ratio MRQ 2.54
Book Value per Share MRQ $1.78

Cash Flow

Operating Cash Flow TTM $265,863,008
Levered Free Cash Flow TTM $98,124,000

ALNY Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 131,791,000
Float Shares 130,251,013
Avg 10 Volume 1,990,010
Avg 30 Volume None
Shares Short 4,184,652
Short Ratio 3.57
Short % of Shares 4.16%
% Held by Insiders 1.47%
% Held by Institutions 100.26%

Stock Price Summary

Beta 0.30
Fifty Two Week Low $205.87
Fifty Two Week High $495.55
Fifty Two Week Change 41.74%
Day 50 MA $436.15
Day 200 MA $371.13

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date